🔎 Trials Near Me

Utama › Adenokarsinoma Esofagus › Arizona

Kajian klinikal Adenokarsinoma Esofagus di Arizona

10 kajian untuk Adenokarsinoma Esofagus sedang mencari peserta di lokasi di Arizona.

Bandar di Arizona

Teks kajian rasmi (Bahasa Inggeris)

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  • Kingman Regional Medical Center, Kingman
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05677490

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

  • City of Hope Cancer Center-Phoenix, Goodyear
  • Mayo Clinic Arizona, Phoenix
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

  • Mayo Clinic, Scottsdale
Mengambil peserta
Umur 18 hingga 89 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05753748

A Study of KK2269 in Adult Participants With Solid Tumors

  • Mayo Clinic Arizona, Scottsdale
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06266299

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

  • Arizona Centers of Digestive Health, Gilbert
Mengambil peserta
Umur 18 hingga 89 · Semua jantina · Dikemas kini 1 Jul 2026 · NCT05530343

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

  • Research Site, Scottsdale
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT07284186

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

  • Mayo Clinic, Scottsdale
Mengambil peserta
Umur 18 hingga 90 · Semua jantina · Dikemas kini 2 Jun 2026 · NCT06071845

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

  • I-Mab Site 1016, Goodyear
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Mei 2026 · NCT07432295

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.